Tumor-Associated Mutations in Caspase-6 Negatively Impact Catalytic Efficiency

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Programmed cell death, or apoptosis, is crucial for preventing cancer.
• Caspase-6 is a key enzyme in apoptosis, and its malfunction is linked to cancer.
• Somatic mutations in the CASP6 gene are found in some tumors.

Purpose of the Study:

• To investigate how CASP6 tumor-associated mutations affect caspase-6 structure and catalytic function.
• To identify specific mutations that impact enzyme activity and understand their molecular mechanisms.

Main Methods:

• Enzyme kinetics assays to measure catalytic efficiency of mutated caspase-6.
• Structural analysis to determine the impact of mutations on enzyme conformation.
• Sequence conservation analysis across the caspase family.

Main Results:

• Most CASP6 mutations decreased the catalytic turnover rate of caspase-6.
• Mutations near the substrate-binding pocket had the most significant deactivating effect.
• The R259H mutation reduced caspase-6 activity 457-fold by disrupting a critical cation-π interaction.

Conclusions:

• CASP6 mutations can lead to catalytically impaired caspase-6.
• Disruption of the Arg-259/Trp-227 interaction is detrimental to caspase-6 function.
• These enzyme-deactivating mutations may play a role in the complex processes of cancer development.